Leo Miller: Page 5
Want to write for BIZ Experiences too? Apply to join BIZ Experiences Leadership network.
Latest: Page 5
Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
Novo Nordisk A/S is moving closer to adding more sales for its blockbuster GLP-1 drug semaglutide to treat a chronic liver disease.
3 Chip and Data Center Stocks That Can Keep Rising in 2025
These chip and/or data center stocks have achieved fantastic returns in 2024. In 2025, they have a good chance to continue their past success.
Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
Cerence is a key competitor to AI-voice recognition stock SoundHound AI in a big industry. See why investors have started to get excited about this name.
3 Top-Performing U.S.-Traded Emerging Market Stocks in 2024
Check out the three best-performing emerging markets stocks of 2024 trading on U.S. exchanges like the NYSE and the NASDAQ.
ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
ORIC Pharmaceuticals is a stock analyst price targets currently signal double-bagger potential in. See what the excitement around this firm is all about.
3 Recession-Resistant Stocks: Low Beta, High Margins, Low Debt
Check out these three stocks with financial metrics showing recession resistance and underlying business dynamics to back them up.
